HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use Doxazosin safely and effectively. See full prescribing information for Doxazosin.
Doxazosin tablets, for oral use
Initial U.S. Approval: 1990
INDICATIONS AND USAGE
Doxazosin is an alpha1 adrenergic antagonist indicated for: (1)
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
WARNINGS AND PRECAUTIONS
The most commonly reported adverse reactions from clinical trials are Fatigue, malaise, hypotension, and dizziness. (6.1)
To report SUSPECTED ADVERSE REACTIONS, contact Greenstone LLC Professional Information Services at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.